7506
Preparation of a C2-symmetry chiral ligand from 4a may be an interesting subject for
investigation and we are now examining an application of the present addition to carbanion-
type nucleophiles and other azoles.††
Reaction of 2a with N,N-dimethylamine (typical procedure). Aq 50% Me2NH (3 ml) was added
to a solution of 2a (3 mmol) in THF (3 ml) at 0°C. Stirring was continued for 3 h at 0°C. Water
(1.5 ml) was added, and the mixture was extracted with AcOEt (20 ml×3). The organic layer was
dried over Na2SO4 and evaporated to give an oily residue, which was purified by column
chromatography (activated alumina) to give 3a (AcOEt/n-hexane=1/1, 88 mg, 15.0%) as the
1
first fraction and 4a (AcOEt, 535 mg, 74.2%) as the second fraction. 3a: oily product. H NMR
(400 MHz, in CDCl3) l 1.06 (s, 9H, ꢀC(CH3)3), 2.34 (s, 6H, ꢀN(CH3)2), 3.38 (s, 1H,
ꢀCHN(CH3)2), 3.64 (s, 3H, NCH3), 6.81 (d, 1H, J=1.3 Hz, ImꢀH), 7.05 (d, 1H, J=1.3 Hz,
ImꢀH). IR (CHCl3): 2926, 1476 cm−1. LR-EIMS m/z (relative intensity): 195 [M+, 5.5], 138
1
(100). HR-EIMS m/z: calcd for C11H21N3, 195.1735. Found: 195.1732. 4a: oily product. H
NMR (400 MHz, in CDCl3) l 1.08 (s, 9H, ꢀC(CH3)3), 2.21 (d, 1H, J=13.6 Hz, ꢀCH2C(CH3)3),
2.24 (s, 6H, ꢀN(CH3)2), 2.26 (d, 1H, J=13.7 Hz, ꢀCH2C(CH3)3), 2.30 (s, 6H, ꢀN(CH3)2), 2.90
(s, 3H, ꢀNCH3), 3.96 (d, 1H, J=3.8 Hz, ꢀCHN(CH3)2), 4.25 (d, 1H, J=3.8 Hz, ꢀCHN(CH3)2).
IR (CHCl3): 2920, 1585 cm−1. LR-EIMS m/z (relative intensity): 240 [M+, 1.7], 138 (100).
HR-EIMS m/z: calcd for C13H28N4, 240.2314. Found: 240.2309. 4a·dipicrate, mp 147.0–150.0°C
(recrystallized from MeOH). Anal. calcd for C25H34N10N14: C, 42.98; H, 4.91; N, 20.05. Found:
C, 43.13; H, 4.95; N, 19.34. X-ray crystallographic data, triclinic; P-1(c2); a=12.2412(8),
3
,
,
b=13.3569(8), c=10.9801(4) A, h=92.526(4), i=94.827(4), k=65.166(5)°; V=1623.4(2) A ;
3
−1
,
Z=2; Dcalc=1.429 g/cm ; u(Cu Ka)=1.54178 A; v(Cu Ka)=10.20 cm ; F(000)=732.00;
T=296 K; R=0.061 (Rw=0.102) for 3505 observations.
Acknowledgements
This research was financially supported in part by the Frontier Research Program of the
Ministry of Education, Science, Sports and Culture of Japan.
References
1. Grimmett, M. R. Advances in Imidazole Chemistry. In Advances in Heterocyclic Chemistry; Katritzky, A. R.;
Boulton, A., Eds. Academic: New York, 1980; Vol. 27, pp. 241–326.
2. For example: (a) Ohta, S.; Hayakawa, S.; Nishimura, K.; Okamoto, M. Chem. Pharm. Bull. 1987, 35, 1058–1069.
(b) Ohta, S.; Yamamoto, T.; Kawasaki, I.; Yamashita, M.; Katsuma, H.; Nasako, R.; Kobayashi, K.; Ogawa, K.;
Chem. Pharm. Bull. 1992, 40, 2681–2685. (c) Ohta, S.; Yamamoto, T.; Kawasaki, I.; Yamashita, M.; Nagashima,
Y.; Yoshikawa, T. Chem. Pharm. Bull. 1994, 42, 821–825. (d) Iddon, B. Heterocycles 1985, 23, 417–443 and
references cited therein.
3. Olofson, A.; Yakushijin, K.; Horne, D. A. J. Org. Chem. 1998, 63, 1248–1253.
4. For example: (a) Begtrup, M. Angew. Chem., Int. Ed. Engl. 1974, 13, 347–347. (b) Itoh, T.; Hasegawa, H.; Nagata,
K.; Ohsawa, A. J. Org. Chem. 1994, 59, 1319–1325. (c) Grimmett, M. In Diazoles, Triazoles, Tetrazoles, and Their
Benzo-analogues; Sammes, P. G., Ed.; Comprehensive Organic Chemistry; Pergamon: Oxford, 1979; Vol. 4, pp
357–410. (d) Regel, E. Liebigs Ann. Chem. 1977, 159–168.
†† New compounds reported in this communication were fully characterized by HRMS (oily compounds),
1
micro-elemental analysis (crystalline compounds), H NMR, IR, and LRMS.